NEW YORK — The National Institutes of Health said on Thursday that it intends to establish new expert panels tasked with identifying genes and genomic variants linked to high-priority disorders.
The so-called Genomic Expert Curation Panels will use the National Human Genome Research Institute's Clinical Genomics Resource (ClinGen), as well as the National Center for Biotechnology Information's ClinVar database of clinical variation, to determine the strength of evidence supporting the clinical significance of the selected genes and variants, the NIH said.